ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $40,605,000 | +146.2% | 519,119 | +39.8% | 3.00% | +74.1% |
| Q1 2020 | $16,493,000 | +47.6% | 371,208 | +41.9% | 1.72% | +71.1% |
| Q4 2019 | $11,171,000 | +324.3% | 261,554 | +324.9% | 1.01% | +203.3% |
| Q3 2019 | $2,633,000 | -91.7% | 61,554 | -87.6% | 0.33% | -89.6% |
| Q2 2019 | $31,617,000 | -8.4% | 497,899 | 0.0% | 3.20% | +0.3% |
| Q1 2019 | $34,534,000 | +78.1% | 497,899 | +96.0% | 3.18% | +82.3% |
| Q3 2018 | $19,390,000 | – | 254,000 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |